INVO Bioscience (INVO) Stock Price, News & Analysis

INVO Bioscience's stock was trading at $1.35 at the beginning of the year. Since then, INVO stock has increased by 1.5% and is now trading at $1.37.
View the best growth stocks for 2024 here.

INVO Bioscience saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 12,100 shares, an increase of 10.0% from the March 15th total of 11,000 shares. Based on an average daily volume of 27,500 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.5% of the shares of the company are short sold.
View INVO Bioscience's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our INVO earnings forecast.

INVO Bioscience, Inc. (NASDAQ:INVO) issued its quarterly earnings results on Monday, November, 15th. The company reported ($4.80) EPS for the quarter, missing the consensus estimate of ($4.00) by $0.80. The company earned $0.22 million during the quarter, compared to analyst estimates of $0.25 million. During the same period in the prior year, the company posted ($7.20) EPS.

INVO Bioscience shares reverse split on Thursday, July 27th 2023. The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.